Emerald Advisers’s Anterix ATEX Stock Holding History
Bought
Maintained
Sold
Other funds holding ATEX
OCAM
HCL
SCM
QF
JCP
Emerald Advisers's ATEX Position: Q1 2023 in Review
Emerald Advisers sold out of Anterix (ATEX) in Q1 2023, closing a stake of 1,100 shares — an estimated $35.4K sold.
Emerald Advisers first reported a position in ATEX in Q2 2020 and held it in 9 quarters. The position peaked at $66K in Q2 2021. 88 funds tracked by Wall St. Rank hold ATEX as of Q1 2023.
- Emerald Advisers reported no remaining Anterix position as of Q1 2023 after selling out during the quarter.
- Emerald Advisers sold 1,100 Anterix shares in Q1 2023, an estimated $35.4K.
- Emerald Advisers first reported a position in Anterix in Q2 2020 and held it in 9 quarters.
- Emerald Advisers's Anterix position peaked at $66K in Q2 2021.
- 88 funds tracked by Wall St. Rank held Anterix as of Q1 2023.
Based on Emerald Advisers's 13F filing for Q1 2023, filed 4 May 2023.